International Flavors & Fragrances (IFF) has published a report identifying ten emerging consumer moments for people using GLP-1 medications. These drugs.

New research shows an exclusive human milk diet may reduce preterm infant mortality by 20% compared to cow milk alternatives.

IFF’s GutABAlite probiotic with Levilactobacillus brevis LBR-6108 may support metabolic health by boosting gut-derived GABA and reducing glucose exposure.

SourceOne's LysOmega improves omega-3 absorption for brain and eye health, addressing nutrient delivery challenges.

Symrise reveals clinical findings showing acerowell’s skin and gut benefits, with new probiotic options for Americas brands at SupplySide Global.

UK MPs urge NHS to reclassify obesity as a chronic condition, addressing inadequate weight-loss services and geographic inequality.

Roquette unifies its health and pharmaceutical divisions to meet rising consumer demands for quality in OTC products, addressing the blurring lines between phar

The campaign to expand the Healthy Start scheme aims to support 750,000 vulnerable families in the UK.

NOW Foods launches metabolic health supplement to support natural GLP-1 production and regulate blood sugar levels.

Evening runs may suit night owls better for performance and recovery, but experts weigh in on how time of day affects runners—especially competitive athletes.